Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Sunday, July 20, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Order Article Reprints
Advertising
Advertising Specs
Online/Web Production

Featured Article

On the Nature of Turf Wars: Disruptive Technologies Did It!
Editor's Letter:
On the Nature of Turf Wars: Disruptive Technologies Did It!

- Frank Criado, MD, Editor-in-Chief




When offered the position of Editor-in-Chief at VDM, I was told that I would have a great deal of freedom to generate my imprint on this publication, and a few privileges; perhaps a little glamour as well. I was also given the “power” to over-rule (if necessary) manuscript reviewers and make some decisions of my own — provided they were rational and based on compelling reasons. Well, I finally found something worthy of such a stance!

The article by Baerlocher, et al. on uterine artery embolization was submitted to VDM and put through the usual peer-review process. The assigned reviewer found it good and interesting, but concluded that the subject would not be of much interest to the VDM readership. When confronted with the issue, and after carefully reading through the paper, I said to myself, “The opportunity to act like an editor-in-chief has finally arrived!” So here we are.

I don’t know just how you — the reader — will react to it, but I would encourage you to read the piece critically, and at least twice. It contains a plethora of rich and well thought-out concepts and definitions that are not readily available.

Turf wars are a huge reality in 21st century vascular medicine, and I think Baerlocher et al. have very succinctly and with utmost clarity put their finger on the precise etiology! “Disruptive technologies” have done it, clearly! And it will continue to happen in the foreseeable future. This is especially true and likely as limited-skills specialists continue to populate the ranks — those are, specialists who possess, by training background and practice, a relatively “limited” set of skills. Surgeons in particular!

Who would have predicted, even just a few years ago, that CT surgeons would be ever described (or defined) as specialists with limited skills?! Vascular surgeons are not far behind… What’s happened here?? Well, they’ve been “disrupted” by the emergence of new technologies that threaten to overtake the old standards of care. Technologies that require new and different skills and training which are a world apart from the “time-honored” conventional approaches and techniques used by specialists who continue to view such patients and pathologies as their “God-given domain.” What’s at stake? Everything! Self-respect, power, money… And it is an unbelievably ego-bruising thing to have happen.

Some of you reading this piece may feel differently. You may say to yourself, “The writing was on the wall long ago! This thing is largely self-inflicted,” and I would agree! I started doing percutaneous transluminal angioplasty (PTA) [for superficial femoral artery (SFA) and iliac artery stenoses] in 1987 — as a vascular surgeon, that is! I don’t know what I would have done as a CT surgeon, but I sense that — at a minimum — I would have explored percutaneous transluminal coronary angioplasty (PTCA) and questioned the stand-by role in the 1980s! At the same time, I must recognize that each and every specialty brings a unique set of skills and patient treatment capabilities to the table. It is not possible (or even realistic) for everyone to be re-invented into an all-knowing, all-adopting vascular or cardio-vascular specialist.

In closing, let me just state — in case any one is in doubt — that the future of vascular and endovascular medicine does not belong to any one group or specialty in particular. But it is undeniable that those physicians who have positioned themselves well, — through skills and appropriate open-mindedness will maximize their opportunities for predominance and success in the challenging and somewhat “hostile” new vascular world of disruptive technologies…


Vascular Disease Management - ISSN: 1553-8036 - Volume 2 Sept/Oct - Issue 5 Sept/Oct - September 2005 - Pages: A2 - A4

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy